Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using PLA2G7 mAb against human PLA2G7 (AA: 22-441) recombinant protein. (Expected MW is 74.6 kDa)Application
Figure 3:Western blot analysis using PLA2G7 mAb against HEK293 (1) and PLA2G7 (AA: 22-441)-hIgGFc transfected HEK293 (2) cell lysate.| Product Name | PLA2G7 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | PAFAD; PAFAH; LP-PLA2; LDL-PLA2 |
| Immunogen | Purified recombinant fragment of human PLA2G7 (AA: 22-441) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBICC/IF |
| WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | PAFAD PAFAH LP-PLA2 LDL-PLA2 |
|---|---|
| Molecular Weight(MW) | 50kDa |
| Entrez Gene | 7941 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using PLA2G7 mAb against human PLA2G7 (AA: 22-441) recombinant protein. (Expected MW is 74.6 kDa)
Application
Figure 3:Western blot analysis using PLA2G7 mAb against HEK293 (1) and PLA2G7 (AA: 22-441)-hIgGFc transfected HEK293 (2) cell lysate.| Application Notes | WB:1:250~1:1000 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
